Paris: Controversial plans to increase the size of Roland Garros, the historic home of the French Open, received a major boost.
The French Tennis Federation (FFT) has been looking at ways to either expand the existing venue in the chic 16th arrondisement of Paris or relocate the French Open to a new site in the capital`s suburbs.
"It would be heart-breaking, but we have to consider it," declared Gilbert Ysern, FFT director general, back in March.
The problem facing the French tennis authorities comes down to space - Roland Garros at 8.5 hectares is less than half the size of Wimbledon, which boasts 18.5 hectares of prime south-west London grass.
Possible new homes that were said to be under consideration in the Parisian `banlieues` were Versailles, Marne-la-Vallee, Evry and Gonesse.But the plan to renovate the existing premises looks to be the favoured option after a special commission made up of elected officials, architects and historians, gave it the thumbs-up by 13 votes for, eight against, with two absentions.
The project proposed jointly by the FFT and Mayor of Paris would involve expanding Roland Garros to create a new 5,000 seater court.
Anne Hidalgo, assistant to Paris mayor Bertrand Delanoe, spoke of "the enthusiastic support from the Paris Mayor`s office for this major project for Paris".
Those against the idea have expressed disquiet at the loss of precious conservation areas surrounding the venue.A final decision on the French Open`s future must be made at the latest by February, 2011.
The French Open was won by the legendary Rene Lacoste the first time it was held in 1925, with Rafael Nadal celebrating his fifth title in June.
Bureau ReportRome: Italian scientist and doctor Ermanno Greco claims to have created a supplement which cures erectile dysfunction and which has been successful in 85 percent of the cases tested.
Greco, who is director of the Centre of Reproductive Biology and Medicine at the European Hospital in Rome, said the supplement has produced excellent results.
"In our test group of 75 patients, we found a positive result in 85 percent of the patients tested," he said.
Greco spoke to AKI ahead of an annual meeting of Italian andrologists opening in Rome Thursday, where he will present the findings of his trial.
"We started from a simple principle: erectile dysfunction is determined by a lack of nitric oxygen in the cells which are needed to create an erection," Greco said.
"We created a substance that can normalise nitric oxygen," he added.
Greco hopes the supplement will offer new hope to men who are tormented by the embarrasing problem of erectile dysfuntion.
"The psychological aspect weighs heavily," Greco said.
IANS
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.